Literature DB >> 18672240

Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population.

Michelle A Miller1, Philip G McTernan, Alison L Harte, Nancy F da Silva, Pasquale Strazzullo, K George M M Alberti, Sudhesh Kumar, Francesco P Cappuccio.   

Abstract

BACKGROUND: Circulating endotoxin levels are associated with atherosclerosis. Moreover, ethnic differences in pro-inflammatory markers may be associated with ethnic differences in atherosclerotic and cardiovascular (CVD) and coronary heart disease (CHD) risk. OBJECTIVE AND METHODS: To investigate ethnic differences in circulating plasma endotoxin levels, its soluble receptor (sCD14), and high-sensitivity CRP (hs-CRP). 192 individuals, aged 40-59 years (61 white (30 women), 68 of African origin (33 women) and 63 South Asians (33 women)), free from coronary heart disease (CHD), stroke, CVD and diabetes were randomly selected from the UK 'Wandsworth Heart and Stroke Study'.
RESULTS: Age-adjusted endotoxin levels were lower in women than in men (p=0.002) and were highest in South Asians (13.3EU/mL [95% CI 12.0-14.7]) and lowest in individuals of African origin (10.1EU/mL [9.1-11.1]) than in whites (p for linear trend <0.001). Endotoxin levels were positively associated with waist, waist-hip ratio, total cholesterol, serum triglycerides and serum insulin levels and negatively associated with serum HDL-cholesterol. Serum hs-CRP and plasma sCD14 varied by ethnic group (p<0.001) but was not associated with endotoxin.
CONCLUSIONS: This study is the first to indicate a graded increase in endotoxin levels from black Africans to whites to South Asians, which is consistent with the ethnic difference in CHD risk. Whilst these findings support the concept that the innate immune system (IIS) may contribute significantly to the metabolic component underlying the development of CVD and CHD risk, further studies are required to see whether endotoxin levels are causally related to the development of CHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672240     DOI: 10.1016/j.atherosclerosis.2008.06.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

Review 1.  Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Authors:  Peter Libby; Joseph Loscalzo; Paul M Ridker; Michael E Farkouh; Priscilla Y Hsue; Valentin Fuster; Ahmed A Hasan; Salomon Amar
Journal:  J Am Coll Cardiol       Date:  2018-10-23       Impact factor: 24.094

2.  Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia.

Authors:  Philipp Wiesner; Soo-Ho Choi; Felicidad Almazan; Christopher Benner; Wendy Huang; Cody J Diehl; Ayelet Gonen; Susan Butler; Joseph L Witztum; Christopher K Glass; Yury I Miller
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

3.  Cyanidin-3-O-beta-glucoside inhibits LPS-induced expression of inflammatory mediators through decreasing IkappaBalpha phosphorylation in THP-1 cells.

Authors:  Yinghui Zhang; Fuzhi Lian; Yanna Zhu; Min Xia; Qing Wang; Wenhua Ling; Xiang-Dong Wang
Journal:  Inflamm Res       Date:  2010-03-23       Impact factor: 4.575

4.  Maternal vitamin D beneficially programs metabolic, gut and bone health of mouse male offspring in an obesogenic environment.

Authors:  C R Villa; J Chen; B Wen; S M Sacco; A Taibi; W E Ward; E M Comelli
Journal:  Int J Obes (Lond)       Date:  2016-10-04       Impact factor: 5.095

Review 5.  Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.

Authors:  Luca Miele; Valentina Giorgio; Maria Adele Alberelli; Erica De Candia; Antonio Gasbarrini; Antonio Grieco
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

Review 6.  Does lipopolysaccharide-mediated inflammation have a role in OA?

Authors:  Zeyu Huang; Virginia Byers Kraus
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

7.  Elevated endotoxin levels in non-alcoholic fatty liver disease.

Authors:  Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

8.  mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells.

Authors:  Huanchun Zhang; W Robert Taylor; Giji Joseph; Valentina Caracciolo; Donna M Gonzales; Neil Sidell; Emre Seli; Perry J Blackshear; Caleb B Kallen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

9.  The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes.

Authors:  Cassie M Mitchell; Brenda M Davy; Tanya M Halliday; Mathew W Hulver; Andrew P Neilson; Monica A Ponder; Kevin P Davy
Journal:  Contemp Clin Trials       Date:  2015-10-28       Impact factor: 2.226

10.  Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation.

Authors:  Z Y Huang; T Stabler; F X Pei; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2016-05-20       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.